Sandbox/MS: Difference between revisions
Amr Marawan (talk | contribs) No edit summary |
Amr Marawan (talk | contribs) No edit summary |
||
Line 6: | Line 6: | ||
|C03=<div style="float: left; text-align: center; width:15em">'''Stage C''' </div> | |C03=<div style="float: left; text-align: center; width:15em">'''Stage C''' </div> | ||
|C04=<div style="float: left; text-align: center; width:15em">'''Stage D'''</div>}} | |C04=<div style="float: left; text-align: center; width:15em">'''Stage D'''</div>}} | ||
{{family tree | |`|-|v|-|'| | |!| | | | | | | | }} | {{family tree | |`|-|v|-|'| | |!| | | | |!| | | }} | ||
{{family tree | | | B01 | | | B02 | | | | | | |B01=<div style="float: left; text-align: left; width:15em">❑ Yearly follow up is recommended with history and physical examination in asymptomatic patients with mild [[MS]] <br>❑ For mild [[MS]] repeat [[echocardiography]] every 3-5 years <br> ❑ For moderate [[MS]] repeat [[echocardiography]] every 1-2 years <br> ❑ The onset of symptoms require medical therapy and re-evaluation of the stage as the patient may also need intervention in moderate and severe disease</div>|B02=<div style="float: left; text-align: left; width:15em"> '''[[Mitral stenosis resident survival guide#Summary for mitral stenosis intervention|Continue with the summary for mitral stenosis intervention below]]'''</div>}} | {{family tree | | | B01 | | | B02 | | | |!| | |B01=<div style="float: left; text-align: left; width:15em">❑ Yearly follow up is recommended with history and physical examination in asymptomatic patients with mild [[MS]] <br>❑ For mild [[MS]] repeat [[echocardiography]] every 3-5 years<ref name="guidelines 2008">{{Cite web | last = | first = | title = 2008 Focused update incorporated into the ACC/AH... [Circulation. 2008] - PubMed - NCBI | url = http://www.ncbi.nlm.nih.gov/pubmed?term=18820172 | publisher = | date = | accessdate = }}</ref> <br> ❑ For moderate [[MS]] repeat [[echocardiography]] every 1-2 years<ref name="guidelines 2008">{{Cite web | last = | first = | title = 2008 Focused update incorporated into the ACC/AH... [Circulation. 2008] - PubMed - NCBI | url = http://www.ncbi.nlm.nih.gov/pubmed?term=18820172 | publisher = | date = | accessdate = }}</ref> <br> ❑ The onset of symptoms require medical therapy and re-evaluation of the stage as the patient may also need intervention in moderate and severe disease</div>|B02=<div style="float: left; text-align: left; width:15em"> '''[[Mitral stenosis resident survival guide#Summary for mitral stenosis intervention|Continue with the summary for mitral stenosis intervention below]]'''</div>}} | ||
{{family tree | | | | | | | {{family tree | | | | | | | | | | | | | B03 | | |B03=<div style="float: left; text-align: left; width:15em">'''''The presence of symptoms is an indication for intervention''''' <br> | ||
{{ | '''Indications for pharmacotherapy:''' <br> ❑ Alleviate symptoms before surgery <br> ❑ Control symptoms precipitated by intercurrent illness or during pregnancy <br> ❑ Persistent symptoms after intervention <br> '''Medications:''' <br> ❑ [[Diuretics]]: used to relieve symptoms of pulmonary vascular congestion (shortness of breath, [[orthopnea]] and [[paroxysmal nocturnal dyspnea]]) and in case of right sided [[heart failure]] <br> ❑ [[Beta blockers]]: useful to control exertional symptoms as it decreases [[heart rate]] and [[cardiac output]] during exercise, thus decreasing the rise in transmitral gradient <br> ❑ [[Digoxin]]: used in case of right or left ventricular systolic dysfunction and also during [[atrial fibrillation]] (not the first line) <br> ❑ [[Statin]] therapy: slower progression of rheumatic [[mitral stenosis]]<ref name="www.ncbi.nlm.nih.gov">{{Cite web | last = | first = | title = Effect of hydroxymethylglutaryl coenzyme-a reduc... [Circulation. 2010] - PubMed - NCBI | url = http://www.ncbi.nlm.nih.gov/pubmed?term=20439789 | publisher = | date = | accessdate = }}</ref> | ||
<br> | |||
{{family tree | | | | | | | '''Antithrombotic recommendations:''' <br> Consider [[anticoagulation therapy]] in [[MS]] patients with: <br> ❑ [[AF]] <br> ❑ Prior embolic event <br> ❑ Left atrial thrombus <br> '''''Long term oral anticoagulation (2.0-3.0 INR)''''' | ||
{{family tree | | | | | | <br> | ||
{{family tree | | | | | | | '''Prevention of endocarditits:''' <br> No longer require antimicrobial prophylaxis </div>}} | ||
{{family tree | | | | | | | | | | | | | |!| | | }} | |||
{{family tree | | | | | | | | | | | | | A01 | |A01=<div style="float: left; text-align: left; width:15em"> '''[[Mitral stenosis resident survival guide#Summary for mitral stenosis intervention|Continue with the summary for mitral stenosis intervention below]]'''</div> }} | |||
{{family tree | | | | | | | | | | | | | | | | | }} | |||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 19:07, 29 April 2014
Classify mitral stenosis based on TTE: ❑ Valve anatomy ❑ Valve hemodynamics gradient ❑ Hemodynamic consequences | |||||||||||||||||||||||||||||||||||||
Stage A | Stage B | Stage C | Stage D | ||||||||||||||||||||||||||||||||||
❑ Yearly follow up is recommended with history and physical examination in asymptomatic patients with mild MS ❑ For mild MS repeat echocardiography every 3-5 years[1] ❑ For moderate MS repeat echocardiography every 1-2 years[1] ❑ The onset of symptoms require medical therapy and re-evaluation of the stage as the patient may also need intervention in moderate and severe disease | |||||||||||||||||||||||||||||||||||||
The presence of symptoms is an indication for intervention Indications for pharmacotherapy: No longer require antimicrobial prophylaxis | |||||||||||||||||||||||||||||||||||||
Classify mitral stenosis based on the following findings on TTE: ❑ Valve anatomy ❑ Valve hemodynamics gradient ❑ Hemodynamic consequences | |||||||||||||||||||||||||||||||||||||
Stage A ❑ Patient at risk of developing mitral stenosis ❑ Mild valve doming during diastole ❑ Normal transmitral flow velocity | Stage B ❑ Progressive mitral stenosis ❑ Valve area > 1.5 cm² ❑ Rheumatic valve changes with commissural fusion and diastolic doming of the mitral valve leaflets ❑ Increased transmitral flow velocities ❑ Diastolic pressure half-time < 150 ms ❑ Mild to moderate left atrial enlargement ❑ Normal pulmonary pressure at rest | Stage C ❑ Asymptomatic severe mitral stenosis ❑ Valve area ≤ 1.5 cm² (≤ 1 cm² in severe mitral stenosis) ❑ Rheumatic valve changes with commissural fusion and diastolic doming of the mitral valve leaflets ❑ Diastolic pressure half-time ≥ 150 ms (≥ 220 ms with very severe mitral stenosis) ❑ Elevated pulmonary artery systolic pressure > 30 mmHg ❑ Severe left atrial enlargement | Stage D ❑ Symptomatic severe mitral stenosis ❑ Valve area ≤ 1.5 cm² (≤ 1 cm² in severe mitral stenosis) ❑ Rheumatic valve changes with commissural fusion and diastolic doming of the mitral valve leaflets ❑ Diastolic pressure half-time ≥ 150 ms (≥ 220 ms with very severe mitral stenosis) ❑ Elevated pulmonary artery systolic pressure > 30 mmHg ❑ Severe left atrial enlargement | ||||||||||||||||||||||||||||||||||
Identify cardinal findings that increase the pretest probability of mitral stenosis ❑ Mid diastolic murmur
| |||||||||||||||||||||||||||||||||||||||||||||
Does the patient have any of the following findings of decompensated mitral stenosis that require urgent management? ❑ Tachycardia ❑ Hypotension ❑ Severe dyspnea ❑ Loss of consciousness ❑ Chest pain | |||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||
What is the complication of mitral stenosis that is causing decompensation? | |||||||||||||||||||||||||||||||||||||||||||||
❑ Suspect in case of:
| ❑ Suspect in case of palpitations ❑ Order an ECG immediately looking for | ❑ Suspect in case of:
| Pulmonary hypertension ± right sided heart failure ❑ Suspect in case of severe dyspnea ❑ Increased jugular venous pressure immediately ❑ Hepatomegaly ± pulsatile liver | ||||||||||||||||||||||||||||||||||||||||||